Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▴
ABOS	Acumen Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$121.33M	n/a	-172.3%	n/a	-$2.00
SLDB	Solid Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$174.32M	n/a	-96.8%	n/a	-$1.99
XFOR	X4 Pharmaceuticals, Inc Manufacturing · Year ended 2025-12-31 · USD	$35.11M	-$79.20M	-225.6%	-42.5%	n/m	-$1.87
INMB	Inmune Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.0K	-$45.93M	n/m	-195.3%	257.1%	-$1.86
LXEO	Lexeo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$99.96M	n/a	-40.5%	n/a	-$1.86
EDIT	Editas Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.52M	-$160.06M	-395.0%	-586.6%	25.4%	-$1.80
OTLK	Outlook Therapeutics, Inc. Manufacturing · Year ended 2025-09-30 · USD	$1.41M	-$62.42M	n/m	n/a	n/a	-$1.79
AURA	Aura Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$106.19M	n/a	-77.6%	n/a	-$1.76
QNCX	Quince Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$83.98M	n/a	n/a	n/a	-$1.68
RLAY	Relay Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$15.36M	-$276.48M	n/m	-48.8%	53.4%	-$1.61
CRBU	Caribou Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.16M	-$148.12M	n/m	-121.2%	11.7%	-$1.59
TARS	Tarsus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$451.36M	-$66.42M	-14.7%	-19.3%	146.7%	-$1.59
NMRA	Neumora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$236.93M	n/a	-228.1%	n/a	-$1.45
RXRX	Recursion Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$74.68M	-$644.76M	-863.4%	-57.0%	26.9%	-$1.44
MGTX	MeiraGTx Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$81.39M	-$114.20M	-140.3%	n/a	144.6%	-$1.42
ALEC	Alector, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.05M	-$142.93M	-679.2%	-466.3%	-79.1%	-$1.39
PRME	Prime Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.63M	-$201.14M	n/m	-166.4%	55.3%	-$1.35
TARA	Protara Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.44M	n/a	-29.2%	n/a	-$1.34
ABPO	Abpro Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$2.89M	n/a	n/a	n/a	-$1.30
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
CCCC	C4 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.95M	-$104.99M	-292.1%	-40.9%	1.0%	-$1.27
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
FATE	Fate Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$6.65M	-$136.31M	n/m	-65.8%	-51.2%	-$1.15
BCLI	Brainstorm Cell Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.31M	n/a	n/a	n/a	-$1.11
EXOZ	Exozymes Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.16M	n/a	-269.6%	n/a	-$1.09

Rows per page: 2550 100